Mostrando 10 resultados de: 36
Publisher
Cold Spring Harbor Laboratory(3)
Cold Spring Harbor Laboratory Preprints(2)
Elsevier(2)
Journal of Global Antimicrobial Resistance(2)
Journal of Medical Entomology(2)
Área temáticas
Enfermedades(22)
Microorganismos, hongos y algas(22)
Medicina forense; incidencia de enfermedades(6)
Fisiología humana(5)
Ginecología, obstetricia, pediatría, geriatría(4)
A case of SARS-CoV-2 reinfection in Ecuador
OtherAbstract:Palabras claves:Autores:Belén Prado-Vivar, Bernardo M. Gutierrez, Gabriel Trueba, Juan José Guadalupe, Michelle Grunauer Andrade, Mónica Becerra-Wong, Patricio Rojas Silva, Paul Andres Cardenas, Paul Cardenas, Sully Márquez, Verónica BarragánFuentes:googlescopusA longitudinal study of E. coli lineages and antimicrobial resistance in Ecuadorian children
OtherAbstract: The gastrointestinal tract (GIT) constitutes a complex and diverse ecosystem. Escherichia coli is onPalabras claves:Autores:Paul CardenasFuentes:googleA longitudinal study of dominant E. coli lineages and antimicrobial resistance in the gut of children living in an upper middle-income country
ArticleAbstract: Objectives: The gastrointestinal tract constitutes a complex and diverse ecosystem. Escherichia coliPalabras claves:Antimicrobial Resistance, E. coli, longitudinal, ECUADOR, Numerically dominant strains, ST131Autores:Belén Prado-Vivar, Diana Calderón, Gabriel Trueba, Graham J.P., Paul Andres Cardenas, Paul CardenasFuentes:googlescopusCharacterization of blaKPC-2-Harboring Klebsiella pneumoniae Isolates and Mobile Genetic Elements from Outbreaks in a Hospital in Ecuador
OtherAbstract: Aim: To investigate the mobile genetic elements harboring blaKPC gene in carbapenem-resistant KlebsiPalabras claves:Autores:Paul CardenasFuentes:googleCharacterization of the Immune Resistance of Severe Acute Respiratory Syndrome Coronavirus 2 Mu Variant and the Robust Immunity Induced by Mu Infection
ArticleAbstract: BACKGROUND: We have recently revealed that the severe acute respiratory syndrome coronavirus 2 (SARSPalabras claves:covid-19, Immune resistance, Mu variant, SARS-COV-2Autores:Erika B. Muñoz, Kosugi Y., Paul Andres Cardenas, Paul Cardenas, Sato K., Shirakawa K., Takaori-Kondo A., Uriu K., Verónica BarragánFuentes:googlescopusCharacterization of the immune resistance of SARS-CoV-2 Mu variant and the immunity induced by Mu infection
OtherAbstract: We have revealed that the SARS-CoV-2 Mu variant is highly resistant to COVID-19 convalescent sera anPalabras claves:Autores:Paul CardenasFuentes:googleBacterial signatures of paediatric respiratory disease: an individual participant data meta-analysis
OtherAbstract: Introduction: The airway microbiota has been linked to specific paediatric respiratory diseases, butPalabras claves:Autores:Paul CardenasFuentes:googleCOVID-19 re-infection by a phylogenetically distinct SARS-CoV-2 variant, first confirmed event in South America.
OtherAbstract: The permanence of rt-PCR positivity after a long time in COVID-19 patients has prompted the questionPalabras claves:Autores:Paul CardenasFuentes:googleAltered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
ArticleAbstract: The SARS-CoV-2 Omicron BA.1 variant emerged in 20211 and has multiple mutations in its spike proteinPalabras claves:Autores:Abdullahi A., Baker S., Belén Prado-Vivar, Bernardo M. Gutierrez, Betancourt A., Bower G., Brevini T., Bucke A., Bullman B., Calder J., Canna L., Charles O.J., Cossetti C., de Sa A., Domingo J., Dougan G., Dunmore B.J., Elmer A., Emma Jones, Epping M., Erika B. Muñoz, Fatihi S., Fawke S., Ferreira I.A.T.M., Fuller S., Gabriel Trueba, Gerber P.P., Gleadall N., Goonawardane N., Graf S., Grenfell R., Harris J., Hess C., Hewitt S., Hinch A., Hodgson J., Huang C., Hunter K., Ikeda T., Jackson S., Jarvis I., Jose S., Juan José Guadalupe, Kemp S.A., Kennet J., Kimura I., Kingston N., Kourampa J., Krishna B., Kuramochi J., Legchenko E., Lehner P.J., Lyons P.A., Mallery D.L., Manuel Eduardo Baldeón, Martin J., Matara C., Mateo Caravajal, Matheson N.J., Maxwell P., Meadows A., Meng B., Mescia F., Michelle Grunauer Andrade, Mitsunaga S., Mónica Becerra-Wong, Nice F., Omarjee O., Ouwehand W.H., O’Brien C., O’Donnell C., Papa G., Patricio Rojas Silva, Paul Andres Cardenas, Paul Cardenas, Perera M., Pointon L., Potts M., Price J., Publico C., Rastall R., Rathore S., Ribeiro C., Richoz N., Romashova V., Rowlands J., Ruffolo V., Saito A., Saunders C., Shaw A., Shih J., Shirakawa K., Stefanucci L., Strezlecki M., Sully Márquez, Summers C., Sutcliffe R., Takaori-Kondo A., Tan T.S., Thaventhiran J.E.D., Tilly T., Tong Z., Tordesillas H., Toshner M., Toyoda M., Treacy C., Turner L., Ueno T., Verónica Barragán, Weekes M.P., Wood J., Wylot M., Yamasoba D., Zepeda S.K.Fuentes:googlescopusEffect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome
ArticleAbstract: Conventional therapy for H. pylori infection includes the combination of antibiotics and a proton-puPalabras claves:ECUADOR, Helicobacter pylori infection, microbiome, probiotics, Saccharomyces boulardii CNCM I-745Autores:Belén Prado-Vivar, Cohen H., Daniela Garcés, Iván Salvador, Manuel Eduardo Baldeón, Marco Vinicio Fornasini, Nancy Flores, Oswaldo Cargua, Paul Andres Cardenas, Paul CardenasFuentes:googlescopus